drugset / Trial / NCT04974073
Development of PHY606 as Adjunct Therapy for Anemia Patients
RandomizedParallel-groupDouble-blindBasic science
Summary
Many reasons can cause anemia, decreased RBC production or increased destruction of circulation RBC. The investigators investigate the Danggui Buxue Tang (PHY606) composed of Angelicae Sinensis Radix and Astragali Radix in the fields of genomic and metabolomics in the healthy people and the patiens with anemia.
Timeline
- Start
- 2017-08-22
- Primary completion
- 2017-08-22
- Completion
- 2019-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PHY606 | Unknown | 7.5 g | — |